Itraconazole Price Trend and Forecast 2026-2027

Itraconazole prices in Germany, the highest-cost reporting region, corrected 5.0% in Q2 2026, slipping from USD 162.7/KG in Q1 to USD 154.6/KG as triazole synthesis feedstock cost softening and post-spring systemic fungal infection and onychomycosis treatment formulation procurement moderation reversed the sustained Q3 2025 through Q1 2026 firming trend. Globally, the average eased from USD 121.4/KG in Q1 to USD 115.3/KG in Q2, a 5.0% decline. For H2 2026, a global average of USD 112-126/KG is expected, with stabilisation as synthesis costs normalise and steady systemic fungal infection, onychomycosis, and prophylaxis treatment sector demand supports the market.

Itraconazole is a synthetic triazole antifungal produced by multi-step synthesis from 1-chloro-4-nitrobenzene, 2,4-dichlorophenyl, and 1,2,4-triazole building blocks through sequential nucleophilic substitution, piperazine coupling, and dioxolane formation steps to yield the 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(1S,2S)-1-ethyl-2-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one stereoisomeric active molecule. The compound selectively inhibits the fungal cytochrome P450 dependent enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol biosynthesis and depleting the fungal cell membrane of its principal sterol, producing broad-spectrum fungistatic and fungicidal activity. The largest pull comes from oral treatment of systemic fungal infections including aspergillosis, histoplasmosis, blastomycosis, and sporotrichosis. Onychomycosis nail infection treatment using pulse dosing oral capsule regimens, prophylaxis in neutropenic haematology patients, and dermatophytosis and oral candidiasis management add further significant demand. Broad-spectrum coverage against dermatophytes and dimorphic fungi, combined with an oral once-daily capsule or solution formulation, supports its established position in empirical and targeted therapy across outpatient and hospital settings. Triazole synthesis intermediate costs, systemic fungal infection incidence and antifungal prescription volumes in both immunocompetent and immunocompromised patient populations, and regional API production capacity all feed into the price.

Itraconazole Price Forecast for 2026

The balance of supply and demand for Itraconazole through H2 2026 leans toward stabilisation following the Q2 correction. Triazole synthesis feedstock costs are normalising. Systemic fungal infection treatment, onychomycosis pulse therapy, and haematology prophylaxis demand provide consistent support at current price levels.

The main upside risk is synthesis feedstock cost increases alongside expanding systemic fungal infection incidence and immunocompromised patient population growth. The main downside risk is Chinese API capacity surplus and newer triazole competition maintaining price pressure below forecast.

For the Quarter Ending June 2026

Itraconazole Prices Q2 2026:

• United States: USD 125.1/KG
• China: USD 86.7/KG
• Germany: USD 154.6/KG
• India: USD 119.5/KG

Itraconazole Prices in the United States

US Itraconazole prices averaged USD 125.1/KG in Q2 2026, down 5.0% from USD 131.7/KG in Q1 2026. Triazole synthesis feedstock cost softening and post-spring systemic fungal and onychomycosis procurement moderation eased the market from the Q1 peak.

Why did the price of Itraconazole change in Q2 2026 in the United States?

Triazole synthesis feedstock cost softening reduced the API production floor. Post-spring systemic fungal infection, onychomycosis pulse therapy, and haematology prophylaxis procurement moderation reduced buying urgency. Generic competition maintained price normalisation near USD 125.1/KG.

Itraconazole Prices in China

Chinese Itraconazole prices averaged USD 86.7/KG in Q2 2026, down 5.0% from USD 91.3/KG in Q1 2026, the lowest among the tracked markets. Soft domestic synthesis costs and post-spring antifungal procurement moderation eased the market from the Q1 peak.

Why did the price of Itraconazole change in Q2 2026 in China?

Soft domestic triazole synthesis feedstock costs reduced the production floor. Post-spring systemic antifungal procurement moderation eased buying urgency. Large domestic API capacity maintained China as the most affordable source near USD 86.7/KG.

Itraconazole Prices in Germany

German Itraconazole prices averaged USD 154.6/KG in Q2 2026, down 5.0% from USD 162.7/KG in Q1 2026, the highest among the tracked markets. Softening synthesis feedstock and energy costs and post-spring systemic antifungal procurement moderation eased the European market from the Q1 firming peak.

Why did the price of Itraconazole change in Q2 2026 in Germany?

Softening triazole synthesis feedstock and energy costs eased the European API production floor. Post-spring systemic fungal, onychomycosis, and prophylaxis procurement moderation reduced urgency. The market corrected to USD 154.6/KG from the Q1 peak.

Itraconazole Prices in India

Indian Itraconazole prices averaged USD 119.5/KG in Q2 2026, down 5.0% from USD 125.8/KG in Q1 2026. Soft synthesis import costs and post-spring systemic antifungal procurement moderation eased the market from the Q1 firming peak.

Why did the price of Itraconazole change in Q2 2026 in India?

Soft triazole synthesis import costs reduced the API production floor. Post-spring systemic fungal and onychomycosis procurement moderation eased buying urgency. Price normalisation held the market near USD 119.5/KG after the Q1 firming peak.

For the Quarter Ending March 2026

Itraconazole Prices Q1 2026:

• United States: USD 131.7/KG
• China: USD 91.3/KG
• Germany: USD 162.7/KG
• India: USD 125.8/KG

Itraconazole Prices in the United States

US prices averaged USD 131.7/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis costs and systemic antifungal and onychomycosis procurement held the market at the Q1 firming peak.

Why did the price of Itraconazole change in Q1 2026 in the United States?

Firmer triazole synthesis feedstock costs raised the API production floor. Systemic fungal infection, onychomycosis pulse, and prophylaxis procurement maintained elevated buying. The market held at USD 131.7/KG before the Q2 feedstock softening correction.

Itraconazole Prices in China

Chinese prices averaged USD 91.3/KG in Q1 2026, up 4.0% from Q4 2025. Firmer domestic synthesis costs and post-Lunar New Year antifungal restocking held the market near USD 91.3/KG.

Why did the price of Itraconazole change in Q1 2026 in China?

Firmer domestic triazole synthesis costs raised the production floor. Post-Lunar New Year systemic antifungal restocking maintained buying. The market held at USD 91.3/KG before the Q2 feedstock softening correction.

Itraconazole Prices in Germany

German prices averaged USD 162.7/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis and energy costs and systemic antifungal and onychomycosis procurement held the European market at the Q1 peak.

Why did the price of Itraconazole change in Q1 2026 in Germany?

Firmer triazole synthesis and energy costs raised the European production floor. Systemic antifungal, onychomycosis, and prophylaxis procurement maintained elevated buying. The market held at USD 162.7/KG before the Q2 synthesis softening correction.

Itraconazole Prices in India

Indian prices averaged USD 125.8/KG in Q1 2026, up 4.0% from Q4 2025. Firmer synthesis import costs and antifungal procurement held the market at the Q1 firming peak.

Why did the price of Itraconazole change in Q1 2026 in India?

Firmer triazole synthesis import costs raised the production floor. Systemic antifungal and onychomycosis procurement maintained elevated buying. The market held at USD 125.8/KG before the Q2 synthesis cost softening correction.

Quarterly Itraconazole Price Trends

Global Itraconazole prices rose steadily through Q3 2025, Q4 2025, and Q1 2026 on firming synthesis costs and consistent systemic antifungal demand before correcting in Q2 2026. The average climbed from USD 110.0/KG in Q2 2025 to USD 112.2/KG in Q3, USD 116.7/KG in Q4, and USD 121.4/KG in Q1 2026, then corrected to USD 115.3/KG in Q2 2026, a net gain of about 4.8% over the window. Triazole synthesis feedstock cycles and systemic antifungal and onychomycosis procurement drove the trajectory.

What was Itraconazole Price in 2025?

Itraconazole prices firmed through 2025 on consistent systemic antifungal and onychomycosis demand. The global average opened near USD 107.7/KG in Q1 2025 and closed at USD 116.7/KG in Q4, a full-year gain of about 8.4%. Triazole synthesis cost firming and antifungal prescription growth drove the trajectory.

Itraconazole Prices in the United States in 2025

US prices firmed from about USD 121.7/KG in Q1 2025 to USD 126.6/KG by Q4, a gain of 4.0%. Consistent systemic antifungal, onychomycosis, and prophylaxis demand supported the upward trend.

Itraconazole Prices in China in 2025

Chinese prices firmed from roughly USD 84.5/KG in Q1 2025 to USD 87.8/KG by Q4, a gain of 3.9%. Growing antifungal export and domestic demand drove the firming through the year.

Itraconazole Prices in Germany in 2025

German prices firmed from about USD 150.4/KG in Q1 2025 to USD 156.4/KG by Q4, a gain of 4.0%. Consistent systemic antifungal, onychomycosis, and prophylaxis demand and firm synthesis costs supported the market.

Itraconazole Prices in India in 2025

Indian prices firmed from roughly USD 116.3/KG in Q1 2025 to USD 121.0/KG by Q4, a gain of 4.0%. Growing antifungal export and domestic demand drove consistent firming.

How We Can Help

Expert Market Research: Your Source for Real-Time Itraconazole Price Intelligence

Expert Market Research tracks Itraconazole prices continuously across every major producing and consuming region. The team traces causation through triazole synthesis feedstock economics, systemic antifungal and onychomycosis prescription cycles, and regional API production capacity. Contact Expert Market Research today for Itraconazole pricing data, bespoke market analysis, and strategic procurement advisory.